LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

Lifevantage Corporation

(RTTNews) - LifeVantage Corp. (LFVN) said it has appointed Raymond Greer as Chairman of the Board. He succeeds Garry Mauro, who will continue to serve as a member of the Board of Directors.
Greer has been an independent director of LifeVantage since 2017. He is an accomplished executive and proven leader with over 35 years of experience encompassing global operations and technology, LifeVantage said in a statement.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Indicator	TTM Median
P/E	21.04 20.90
Price/Sales	0.72 0.83
P/B	4.95 1.82
P/FCF	12.11 19.11

Indicator	TTM Median
ROE	28.83 13.30
ROA	12.75 5.85
ROI	0.00 9.19
Net Worth	0.16 1.38
Quick Ratio	1.03 0.86
Current Ratio	1.66 1.37

Indicator	TTM Median
Net Profit Margin	3.77 5.78
Operating Margin	5.19 9.26
Gross Margin	80.19 34.60
Return on tangible equity	29.36 24.12

Indicator	TTM Median
EPS	0.26 0.51
EPS Forecast	0.00 0.41
Revenue	68.00M 141.00M
Gross Profit	55.00M —
EBITDA	4.00M —

Lifevantage Corporation

Fundamental LFVN

Valuation

Debts

Efficiency

Other ratios

Revenue